AURX

$0.83+$0.00 (+0.00%)live

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$0.83 – $3.23

0% from low

Exchange

OTC Link

Change+$0.83

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$6M	+85.3%	$-0.04	$-0.04–$-0.04	—	1
2027	$10M	+66.7%	$-0.01	$-0.01–$-0.01	—	1
2028	$14M	+45.0%	$0.01	$0.01–$0.01	83.0×	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Beat consensus in 2 of the last 2 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-05-14	$-0.01	$-0.01	+0.0%
2026-02-25	$-0.01	$-0.01	+0.0%

Symbol	Price	Today	Mkt cap	P/E
AURXNuo Therapeutics, Inc.	$0.83	+0.00%	$40M	—
GGBXFGreen Growth Brands Inc.	$0.00	+0.00%	$2061	—
HOFBFHofseth BioCare ASA	$0.17	+0.00%	$68M	—
IUGNFImugene Limited	$0.08	+0.00%	$37M	—
KNTPFKintor Pharmaceutical Limited	$0.24	+0.00%

No one on the platform currently holds AURX.

Institutions holding (13F)

No tracked institution reports a position in AURX as of their last filing.

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

No one on the platform has traded AURX yet.